Parkman Healthcare Partners’s Cullinan Oncology CGEM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-178,396
| Closed | -$3.04M | – | 92 |
|
|
2024
Q1 | $3.04M | Sell |
178,396
-351,481
| -66% | -$5.99M | 0.37% | 72 |
|
|
2023
Q4 | $5.4M | Buy |
529,877
+91,132
| +21% | +$929K | 0.76% | 40 |
|
|
2023
Q3 | $3.97M | Buy |
438,745
+91,964
| +27% | +$832K | 0.73% | 39 |
|
|
2023
Q2 | $3.73M | Buy |
346,781
+176,895
| +104% | +$1.9M | 0.65% | 50 |
|
|
2023
Q1 | $1.74M | Buy |
169,886
+38,508
| +29% | +$394K | 0.38% | 60 |
|
|
2022
Q4 | $1.39M | Buy |
+131,378
| New | +$1.39M | 0.37% | 65 |
|